Kefavet® vet. 250 mg, film-coated tablet
Kefavet® vet. 250 mg, film-coated tablet
Not authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Kefavet® vet. 250 mg, film-coated tablet
Kefavet Vet 250 mg Filmomhulde tablet
Kefavet Vet 250 mg Comprimé pelliculé
Kefavet Vet 250 mg Filmtablette
Active substance:
- Cefalexin monohydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate263.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Blister, 28 tablets
- Blister, 70 tablets
- Blister, 140 tablets
- Blister, 14 tablets
- Blister, 20 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Prodivet Pharmaceuticals
Marketing authorisation date:
Manufacturing sites for batch release:
- Orion Corporation
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V330924
Date of authorisation status change:
Reference member state:
-
Sweden
Procedure number:
- SE/V/0114/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
